Verma Anjali, Lata Kusum, Khanna Alok, Singh Raj, Sachdeva Ashuma, Jindal Prateek, Yadav Swati
Department of Pediatrics, PGIMS, Rohtak, Haryana, India.
Department of Orthopedics, PGIMS, Rohtak, Haryana, India.
J Family Med Prim Care. 2022 Feb;11(2):603-607. doi: 10.4103/jfmpc.jfmpc_1190_21. Epub 2022 Feb 16.
Celiac disease (CD) is a multifactorial immune-mediated enteropathy caused by a response to ingested gluten. The current available treatment for CD is lifelong gluten-free diet (GFD). This study was done to see the effect of GFD on Vitamin D levels and bone mass density in celiac patients.
A prospective interventional study on newly diagnosed celiac patients was conducted in the Pediatrics department of a tertiary care teaching institute in 2 stages viz. on presentation and after 6 months of GFD. Anthropometric measurements, biochemical investigations, Vitamin D levels, and DEXA scan was done at recruitment and after 6 months of GFD and was analyzed.
In newly diagnosed 60 pediatric celiac patients, positive effect of GFD on anthropometry, hemoglobin, Vitamin D levels, DEXA scan parameters was observed. Significant difference was found in Vitamin D levels which increased from baseline 14.85 ± 5.39 to 18.22 ± 5.67 ng/ml after 6 months of GFD ( < 0.05). Significant difference was found in BMD (mean Z-score) which increased from -0.941 ± 0.738 to -0.640 ± 0.60 after 6 months of GFD ( < 0.001).
Our study concluded that there is significant increase in vitamin D levels as well as Z-score, bone mass density (BMD) and bone Mass Content (BMC) after 6 months of GFD.
乳糜泻(CD)是一种由摄入麸质引发的多因素免疫介导性肠病。目前针对CD的可用治疗方法是终身无麸质饮食(GFD)。本研究旨在观察GFD对乳糜泻患者维生素D水平和骨密度的影响。
在一所三级护理教学机构的儿科对新诊断的乳糜泻患者进行了一项前瞻性干预研究,分两个阶段进行,即就诊时和GFD治疗6个月后。在招募时以及GFD治疗6个月后进行人体测量、生化检查、维生素D水平检测和双能X线吸收法扫描,并进行分析。
在新诊断的60例儿科乳糜泻患者中,观察到GFD对人体测量、血红蛋白、维生素D水平、双能X线吸收法扫描参数有积极影响。维生素D水平有显著差异,GFD治疗6个月后从基线的14.85±5.39 ng/ml升至18.22±5.67 ng/ml(P<0.05)。骨密度(平均Z值)有显著差异,GFD治疗6个月后从-0.941±0.738升至-0.640±0.60(P<0.001)。
我们的研究得出结论,GFD治疗6个月后,维生素D水平以及Z值、骨密度(BMD)和骨量(BMC)均有显著增加。